DHR
Danaher Corporation · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang -4.0% ·
aliran saham +4.8% ·
posisi baru bersih -4.2%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 294.05K | $63.57M | n/a | −3 |
| Q2 2026 | 188 | +7 | 434.91M | $82.90B | +10 | −4 |
| Q1 2026 | 185 | -2 | 440.89M | $83.51B | +5 | −8 |
| Q4 2025 | 186 | -1 | 467.58M | $107.03B | +2 | −2 |
| Q3 2025 | 30 | -1 | 269.80M | $53.47B | +1 | −3 |
| Q2 2025 | 29 | +2 | 237.37M | $46.89B | +3 | −1 |
| Q1 2025 | 24 | -1 | 116.89M | $23.96B | +1 | −2 |
| Q4 2024 | 25 | +1 | 111.55M | $25.60B | +1 | n/a |
| Q3 2024 | 23 | +1 | 81.67M | $22.69B | +2 | −1 |
| Q2 2024 | 22 | n/a | 81.37M | $20.32B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 27.46M | +0.3% | $5.64B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 19.59M | +3.2% | $4.02B | 0.5% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 17.70M | -17.0% | $3.63B | 0.7% | ▼ Trim | 4 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (pasif) | 13.64M | +2.1% | $2.79B | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (pasif) | 9.67M | +4.2% | $1.98B | 0.3% | ▲ Add | 4 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 4.64M | +1.2% | $950.20M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 7 | Capital World Investors ✦ | 4.09M | -35.7% | $838.73M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Marshall Wace ✦ | 3.61M | +709.1% | $739.23M | 1.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 9 | Point72 Asset Management ✦ | 3.16M | +134.6% | $648.53M | 1.9% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 2.64M | +349.1% | $540.38M | 0.5% | ▲ Add | 4 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 2.55M | +20.6% | $522.71M | 0.7% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Arrowstreet Capital ✦ | 2.23M | +177.5% | $457.18M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.98M | +212.0% | $404.89M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 1.11M | +7.6% | $226.65M | 0.5% | ▲ Add | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 981.43K | +124.4% | $201.19M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 747.39K | +98.3% | $150.43M | 0.2% | ▲ Add | 4 | SEC ↗ ×6 |
| 17 | Viking Global Investors ✦ | 451.52K | Baru | $92.56M | 0.3% | New | 1 | SEC ↗ |
| 18 | Gates Foundation Trust ✦ | 373.00K | 0.0% | $76.47M | 0.2% | Held | 4 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 121.00K | +875.7% | $24.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 73.60K | +29.0% | $15.09M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 40.00K | -69.3% | $8.20M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 22 | Dodge & Cox ✦ | 16.52K | 0.0% | $3.39M | 0.0% | Held | 4 | SEC ↗ |
| 23 | Harris Associates (Oakmark) ✦ | 15.62K | -11.6% | $3.20M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | GAMCO Investors ✦ | 1.61K | -38.6% | $330,050 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Viking Global Investors | $92.56M | 0.3% |
Telah keluar
| Third Point | $436.14M | adalah 5.9% |
| Bridgewater Associates | $287,856 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 2,147 pemegang, 548.39M saham, $97.77B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 11.31K lbr · $2.46M
Officer, Director · 39.19K lbr · $8.57M
Officer, Director · 7.75K lbr · $1.70M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi